Cargando…

A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases

Immunosuppression is an important risk factor for leishmaniasis. We assessed the clinical profile, geographic distribution and prevalence of leishmaniasis in patients undergoing immunosuppressive therapy for dermatological, rheumatological or gastroenterological autoimmune diseases. We identified re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurizky, Patrícia Shu, Marianelli, Fernanda Ferraço, Cesetti, Mariana Vicente, Damiani, Giovanni, Sampaio, Raimunda Nonata Ribeiro, Gonçalves, Lais Mitsue Tanaka, de Sousa, Carlos Augusto Felipe, Martins, Sofia Sales, Vernal, Sebastian, da Mota, Licia Maria Henrique, Gomes, Ciro Martins
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto de Medicina Tropical 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232954/ https://www.ncbi.nlm.nih.gov/pubmed/32401957 http://dx.doi.org/10.1590/S1678-9946202062028

Ejemplares similares

Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis
por: Barroso, Daniel Holanda, et al.
Publicado: (2021)

Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis()()
por: Barroso, Daniel Holanda, et al.
Publicado: (2021)

Recurrent cutaneous leishmaniasis*
por: Gomes, Ciro Martins, et al.
Publicado: (2013)

Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis()()
por: Sampaio, Raimunda Nonata Ribeiro, et al.
Publicado: (2021)

The paradox of tegumentary leishmaniasis diagnosis: How the need for accurate and modern techniques is being addressed in low income areas
por: Kurizky, Patrícia Shu, et al.
Publicado: (2018)

The accuracy of the Montenegro skin test for leishmaniasis in PCR-negative patients
por: Pinheiro, Ana Bárbara Sapienza, et al.
Publicado: (2020)

Complementary exams in the diagnosis of american tegumentary leishmaniasis
por: Gomes, Ciro Martins, et al.
Publicado: (2014)

Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis
por: Gomes, Ciro Martins, et al.
Publicado: (2015)

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis
por: Rodrigues, Bruna Côrtes, et al.
Publicado: (2020)

The Presence of Leishmania braziliensis DNA in the Nasal Mucosa of Cutaneous Leishmaniasis Patients and the Search for Possible Clinical and Immunological Patterns of Disease Progression: A Cross Sectional Study
por: Barroso, Daniel Holanda, et al.
Publicado: (2021)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
por: Martins, Sofia Sales, et al.
Publicado: (2021)

Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance
por: Soares, Killarney Ataide, et al.
Publicado: (2015)

No evidence for cardiotoxicity of miltefosine – Reply()
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis
por: Barroso, Daniel Holanda, et al.
Publicado: (2018)

Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician
por: Moots, Robert, et al.
Publicado: (2017)

Lutzomyia whitmani is the main vector of American Cutaneous Leishmaniasis in the Brazilian Federal District and the most prevalent species in residential areas of the Administrative Region of Sobradinho()
por: Barreto, Mariana Boff, et al.
Publicado: (2014)

Evaluation of the occurrence of sexual dysfunction and general quality of life in female patients with psoriasis
por: Kurizky, Patricia Shu, et al.
Publicado: (2018)

The interference of polypharmacy and the importance of clinical pharmacy advice in the treatment of leprosy: a case-control study
por: Cerqueira, Selma Regina Penha Silva, et al.
Publicado: (2020)

Immunosuppressives and biologics during pregnancy and lactation: A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation
por: Puchner, Antonia, et al.
Publicado: (2019)

Foreword: Seminars in Research 2014 Joint Experiences in Rheumatology and Dermatology
por: Costanzo, Antonio, et al.
Publicado: (2016)

Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
por: Werth, Victoria P., et al.
Publicado: (2021)

Oral health in patients with severe inflammatory dermatologic and rheumatologic disease
por: Kiernan, Yvonne, et al.
Publicado: (2022)

Disseminated Leishmaniasis by Leishmania viannia Subgenus: A Series of 18 Cases in Southeastern Brazil
por: Vernal, Sebastian, et al.
Publicado: (2016)

The challenge of concomitant infections in the coronavirus disease 2019 pandemic era: Severe acute respiratory syndrome coronavirus 2 infection in a patient with chronic Chagas disease and dimorphic leprosy
por: Kurizky, Patricia Shu, et al.
Publicado: (2020)

From Rheumatology 1.0 to Rheumatology 4.0 and beyond: the contributions of Big Data to the field of rheumatology
por: Bragazzi, Nicola Luigi, et al.
Publicado: (2019)

Effectiveness of interdisciplinary combined dermatology–gastroenterology–rheumatology clinical care compared to usual care in patients with immune-mediated inflammatory diseases: a parallel group, non-blinded, pragmatic randomised trial
por: Hjuler, Kasper Fjellhaugen, et al.
Publicado: (2021)

National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)
por: Rath, Eva, et al.
Publicado: (2022)

Exploring Dermatomyositis through an Interdisciplinary Lens: Pearls from Dermatology and Rheumatology
por: Kassamali, Bina, et al.
Publicado: (2021)

Towards a combined pediatric rheumatology-dermatology clinic: One-year experience
por: Demirkan, Fatma Gul, et al.
Publicado: (2020)

Case Report: A Case Series of Immunobiological Therapy (Anti-TNF-α) for Patients With Erythema Nodosum Leprosum
por: Mendes, Ana Flávia Moura, et al.
Publicado: (2022)

Non-tuberculous cutaneous mycobacterioses()()
por: Nogueira, Lais Bastos, et al.
Publicado: (2021)

Observational study of intraocular lens tilt in sutureless intrascleral fixation versus standard transscleral suture fixation determined by ultrasound biomicroscopy
por: Marianelli, Bruna Ferraço, et al.
Publicado: (2019)

Big Data in Gastroenterology Research
por: Alizadeh, Madeline, et al.
Publicado: (2023)

A histopathological and biometric comparison between catfish (Pisces, Ariidae) from a harbor and a protected area, Brazil
por: Carvalho Neta, Raimunda Nonata Fortes, et al.
Publicado: (2014)

Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?
por: Fleischmann, Roy, et al.
Publicado: (2020)

Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines
por: Busger op Vollenbroek, Felien T. M., et al.
Publicado: (2018)

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology
por: Jessica Chang, Ting Yi, et al.
Publicado: (2020)

A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19
por: Bieber, Thomas, et al.
Publicado: (2022)

Should children with psoriasis be consulted to a rheumatologist? Result from pediatric rheumatology-dermatology collaboration
por: Karadag, Serife Gul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d09dtuq2ccpjljl6rhr0j42n83